Back
Easterly Government Properties, Inc. Vs. Nektar Therapeutics Industry Stock Comparison
Sell
30
DEA
Easterly Government Properties, Inc.
Last Price:
$21.20
Seasonality Move:
-4.81%
Sell
42
NKTR
Nektar Therapeutics
Last Price:
$43.48
Seasonality Move:
6.44%
Sell
30
Easterly Government Properties, Inc. (DEA)
is a Sell
Is Easterly Government Properties, Inc. a Buy, Sell or Hold?
-
The current Easterly Government Properties, Inc. [DEA] share price is $21.21. The Score for DEA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
DEA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $43.48. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DEA Stock Price Chart
What is Easterly Government Properties, Inc.'s stock price today?
-
The Easterly Government Properties, Inc. share price today is $21.21Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DEA is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $43.48Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
DEA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 40.24 | Sell |
| Chaikin Money Flow: | -393547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.2 - 22.1) | Sell |
| Bollinger Bands (100): | (21.49 - 22.81) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.36 | Sell |
| Relative Strength Index (14 RSI): | 35.32 | Sell |
| Chaikin Money Flow: | -1120535 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.64 - 61.4) | Sell |
| Bollinger Bands (100): | (35.47 - 62.69) | Sell |
DEA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.92 | Sell |
| 20-day SMA: | 21.83 | Sell |
| 50-day SMA: | 21.7 | Sell |
| 200-day SMA: | 22.45 | Sell |
| 8-day EMA: | 21.76 | Sell |
| 20-day EMA: | 21.77 | Sell |
| 50-day EMA: | 21.83 | Sell |
| 200-day EMA: | 23.29 | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.5 | Sell |
| 20-day SMA: | 54.97 | Sell |
| 50-day SMA: | 57.15 | Sell |
| 200-day SMA: | 31.68 | Buy |
| 8-day EMA: | 48.23 | Sell |
| 20-day EMA: | 52.53 | Sell |
| 50-day EMA: | 53.87 | Sell |
| 200-day EMA: | 38.39 | Buy |
Easterly Government Properties, Inc. Earnings Growth & DEA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
Easterly Government Properties, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||